Theratechnologies data suggests tesamorelin may improve ... - The Science Board

Theratechnologies data suggests tesamorelin may improve … – The Science Board

Please note that 02xl.com provides this information for the benefit of the disease community. 02xl.com is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.

Metabolic syndrome is characterized by central adiposity, high levels of fasting blood glucose, high blood levels of triglycerides, low blood levels of high-density lipoprotein cholesterol, and hypertension. The syndrome is also associated with increased risk of cardiovascular disease, stroke, and type 2 diabetes.

EVAF, an important component of central adiposity, contributes to obesity-related disorders and is associated with ectopic (abnormal) fat accumulation in the liver, including nonalcoholic fatty liver disease. Some individuals with liver fat can develop nonalcoholic steatohepatitis (NASH), an aggressive form of fatty liver disease, which is marked by liver inflammation and may progress to advanced scarring (cirrhosis) and liver failure.

In a presentation last month at the 30^th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, Theratechnologies researchers reported an association between EVAF reduction and positive change in metabolic syndrome classification in people with HIV treated with tesamorelin.

“Our findings of EVAF reduction and reversal of metabolic syndrome classification following treatment with tesamorelin are consistent with previous data indicating an association between visceral fat reduction and improved metabolic profiles in [people with HIV],” lead investigator Dr. Roger Bedimo, a professor of internal medicine at the University of Texas Southwestern Medical Center, said in a statement.

Related Reading

Adblock test (Why?)

Share your experience. Everybody’s experience of Overweight & Obesity is different. There are many ways to address people’s lived experience of Overweight & Obesity, that must work for the individual. Sharing your story can help change perspectives and inspire others who may feel alone and unrepresented. You can also hear from other people about their experience of Overweight & Obesity.

Thanks for being there: We need your help. The 02xl Overweigt & Obesity Community continues to grow but revenues have never been harder to maintain.
With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.